---
title: FDA Accepts Glauko's NDA for Epioxa
description: Glaukos's Epioxa NDA acceptance marks a breakthrough in keratoconus treatment, offering a faster, non-invasive alternative to traditional therapies.
image: https://visionexecutives.com/hubfs/Keratoconus%20Treatment.png
---

[Skip to content](https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa#main-content)

[![Vision Executives Logo](https://visionexecutives.com/hubfs/Color%20logo%20with%20white%20text.svg)](https://www.visionexecutives.com/)

- [About](https://visionexecutives.com/about-us)
- Recruitment Services
  
  Show submenu for Recruitment Services 
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [FREE Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
- Candidate Services
  
  Show submenu for Candidate Services 
  
    - [Representing You](https://visionexecutives.com/representing-you)
    - [CV & LinkedIn Writing Service](https://visionexecutives.com/our-packages)
- [Our Vacancies](https://visionexecutives.com/vacancies)
- News & Insights
  
  Show submenu for News & Insights 
  
    - [Latest News & Articles](https://visionexecutives.com/blog)
    - [Eyewear & Optics Salary Report](https://visionexecutives.com/eyewear-optical-industry-salary-report)
    - [Optometrist & Ophthalmologist Salary Report](https://visionexecutives.com/optometrist-ophthalmologist-salary-report)
- [Contact](https://visionexecutives.com/contact-us)

Open main navigation

Close main navigation

- [About](https://visionexecutives.com/about-us)
- Recruitment Services
  
  Show submenu for Recruitment Services 
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [FREE Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
- Candidate Services
  
  Show submenu for Candidate Services 
  
    - [Representing You](https://visionexecutives.com/representing-you)
    - [CV & LinkedIn Writing Service](https://visionexecutives.com/our-packages)
- [Our Vacancies](https://visionexecutives.com/vacancies)
- News & Insights
  
  Show submenu for News & Insights 
  
    - [Latest News & Articles](https://visionexecutives.com/blog)
    - [Eyewear & Optics Salary Report](https://visionexecutives.com/eyewear-optical-industry-salary-report)
    - [Optometrist & Ophthalmologist Salary Report](https://visionexecutives.com/optometrist-ophthalmologist-salary-report)
- [Contact](https://visionexecutives.com/contact-us)
- [EYE-INTRO Login](https://vision-executives.i-intro.net/)

[EYE-INTRO Login](https://vision-executives.i-intro.net/)

# FDA Accepts Glauko's NDA for Epioxa

Mar 14, 2025, 8:44:08 AM

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives)

Share: [facebook-f icon](http://www.facebook.com/share.php?u=https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa) [twitter icon](https://twitter.com/intent/tweet?url=https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa) [envelope icon](mailto:?body=https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa)

𝐅𝐃𝐀 𝐀𝐜𝐜𝐞𝐩𝐭𝐬 𝐆𝐥𝐚𝐮𝐤𝐨𝐬'𝐬 𝐍𝐃𝐀 𝐟𝐨𝐫 𝐄𝐩𝐢𝐨𝐱𝐚: 𝐀 𝐍𝐞𝐰 𝐄𝐫𝐚 𝐢𝐧 𝐊𝐞𝐫𝐚𝐭𝐨𝐜𝐨𝐧𝐮𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭

👁 The acceptance of [Glaukos Corporation](https://www.linkedin.com/company/glaukos-corporation/)’s NDA for Epioxa marks a significant advancement in treating keratoconus, a condition where the cornea weakens and bulges, causing vision distortion. Epioxa offers a faster, non-invasive treatment option compared to traditional corneal cross-linking therapies, which require epithelium removal.

🏥 In the UK, patients have benefited from local access to corneal cross-linking at Musgrove Park Hospital, which has improved their vision and stabilized the condition. This procedure has a 95% success rate, providing hope for many patients with this debilitating disease.

## Related posts

[![](https://visionexecutives.com/hs-fs/hubfs/Topcon%20Heathcare%20Funding%20%26%20Collaboration.png?height=200&name=Topcon%20Heathcare%20Funding%20%26%20Collaboration.png)](https://visionexecutives.com/blog/topcon-healthcare-partners-with-radiusxr-glaukos-next-gen-platform)

## [Topcon Healthcare Partners with RadiusXR & Glaukos Next-Gen Platform](https://visionexecutives.com/blog/topcon-healthcare-partners-with-radiusxr-glaukos-next-gen-platform)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Mar 27, 2025, 10:53:51 AM

𝐓𝐨𝐩𝐜𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐞𝐚𝐝𝐬 𝐦𝐚𝐜𝐡𝐢𝐧𝐞𝐌𝐃’𝐬 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐑𝐨𝐮𝐧𝐝 𝐚𝐧𝐝...

[Read more](https://visionexecutives.com/blog/topcon-healthcare-partners-with-radiusxr-glaukos-next-gen-platform)

[![](https://visionexecutives.com/hs-fs/hubfs/ViaLase%20Content%20Post.png?height=200&name=ViaLase%20Content%20Post.png)](https://visionexecutives.com/blog/vialase-secures-40m-funding-for-revolutionary-glaucoma-treatment)

## [ViaLase Secures $40M Funding for Revolutionary Glaucoma Treatment](https://visionexecutives.com/blog/vialase-secures-40m-funding-for-revolutionary-glaucoma-treatment)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Apr 25, 2024, 9:53:10 AM

💲𝐕𝐢𝐚𝐋𝐚𝐬𝐞 𝐒𝐞𝐜𝐮𝐫𝐞𝐬 $40𝐌 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐟𝐨𝐫 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐚𝐫𝐲...

[Read more](https://visionexecutives.com/blog/vialase-secures-40m-funding-for-revolutionary-glaucoma-treatment)

[![](https://visionexecutives.com/hs-fs/hubfs/Nidek%20Tomography%20-%20Content%20Post.png?height=200&name=Nidek%20Tomography%20-%20Content%20Post.png)](https://visionexecutives.com/blog/nidek-launches-rs-1-glauvas-optical-coherence-tomography)

## [Nidek Launches RS-1 Glauvas Optical Coherence Tomography](https://visionexecutives.com/blog/nidek-launches-rs-1-glauvas-optical-coherence-tomography)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Jun 17, 2024, 1:29:41 PM

𝐍𝐢𝐝𝐞𝐤 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬 𝐑𝐒-1 𝐆𝐥𝐚𝐮𝐯𝐚𝐬 𝐎𝐩𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐜𝐞...

[Read more](https://visionexecutives.com/blog/nidek-launches-rs-1-glauvas-optical-coherence-tomography)

[![Vision Executives Logo](https://visionexecutives.com/hubfs/Color%20logo%20with%20white%20text.svg "Vision Executives Logo")](https://visionexecutives.com/)

Vision Executives International Ltd  
HUB26  
Hunsworth Lane

Cleckheaton  
BD19 4LN  
​United Kingdom

 

[   +44 (0) 113490 0340](tel:4401134900340)

[mailto:info@visionexecutives.com](mailto:info@visionexecutives.com)   [info@visionexecutives.com](mailto:info@visionexecutives.com)  
<https://www.linkedin.com/company/vision-executives/?originalSubdomain=uk>  [Follow us on LinkedIn](https://www.linkedin.com/company/vision-executives/?originalSubdomain=uk)

- **Quick Links**
  
    - [Home](https://visionexecutives.com)
    - [About](https://visionexecutives.com/about-us)
    - [News & Insights](https://visionexecutives.com/blog)
    - [Contact us](https://visionexecutives.com/contact-us)
    - [Vacancies](https://visionexecutives.com/vacancies)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
    - EYE-INTRO Login
- **Services**
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Representing You](https://visionexecutives.com/representing-you)
    - [CV & LinkedIn Writing Service](https://visionexecutives.com/our-packages)

<iframe class="hs-responsive-embed-iframe" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: none;" xml="lang" src="https://www.google.com/maps/embed?pb=!1m14!1m8!1m3!1d1236136.8347097263!2d-2.72842621664985!3d52.66548923511256!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x487be19725160b51%3A0xb3b9cbfc92600618!2sVision%20Executives!5e0!3m2!1sen!2suk!4v1689253568813!5m2!1sen!2suk" width="600" height="450" allowfullscreen loading="lazy" data-service="google-maps"></iframe>

---

Website designed by [Xtra Mile Marketing](https://www.xtramilemarketing.co.uk/)

Copyright © 2026, Vision Executives

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Vision Executives",
    "url" : "https://visionexecutives.com/blog/author/vision-executives"
  },
  "dateModified" : "2025-03-14T08:44:08.976Z",
  "datePublished" : "2025-03-14T08:44:08.000Z",
  "headline" : "FDA Accepts Glauko's NDA for Epioxa",
  "image" : [ "https://visionexecutives.com/hubfs/Keratoconus%20Treatment.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://visionexecutives.com/hubfs/Globals/vision%20executives%20logo.png"
    },
    "name" : "Vision Executives"
  }
}
```